Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Boundless Bio, Inc. (BOLD) had Free Cash Flow of $-36.68M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-13.88M |
|
-- |
|
-- |
|
$15.15M |
|
$-15.15M |
|
$1.27M |
|
$-13.88M |
|
$-13.88M |
|
$-13.88M |
|
$-13.88M |
|
$-13.88M |
|
$-13.88M |
|
$-15.15M |
|
$-14.84M |
|
22.39M |
|
22.39M |
|
$-0.62 |
|
$-0.62 |
|
| Balance Sheet Financials | |
$120.16M |
|
$3.50M |
|
$48.56M |
|
$168.72M |
|
$11.85M |
|
$46.71M |
|
$46.71M |
|
$58.55M |
|
$110.17M |
|
$110.17M |
|
$110.17M |
|
22.39M |
|
| Cash Flow Statement Financials | |
$-36.55M |
|
$24.83M |
|
$0.12M |
|
$27.15M |
|
$15.54M |
|
$-11.61M |
|
$4.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.14 |
|
-- |
|
-- |
|
0.30 |
|
0.45 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-36.68M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.60% |
|
-12.60% |
|
-8.23% |
|
-8.85% |
|
$4.92 |
|
$-1.64 |
|
$-1.63 |
|